But use of these drugs actually leads to a significant increase in sudden death in patients with asymptomatic ventricular arrhythmias after a heart attack. For these patients, the reduced post-treatment rate of ventricular arrhythmias is not indicative of improved survival and is therefore not a good proxy metric.
